Chromoendoscopy Agents Market Size, Share & Industry Analysis, By Product Type (Reactive Agents, Contrast Agents, Absorptive Agents), By Application (Gastrointestinal Diseases, Colorectal Diseases, Esophageal Diseases, Others), By End User (Hospitals, Diagnostic Laboratories, Clinics, Others) And Regional Forecast, 2024-2032

Early detection of cancer and malignancy is the key to successful treatment and clinical outcomes. Gastric and colorectal cancer can be easily detected through endoscopy. However, conventional endoscopy has certain limitations in detecting small lesions, which increases the miss rate. Chromoendoscopy has considerably improved the detection of lesions, particularly in ulcerative colitis, Crohn’s disease, and others. Chromoendoscopy, also called chromoscopy, is a method where a chemical stain is sprayed on the mucosal surface to detect changes in the epithelial cells. The technique facilitates the visualization of minute changes in the mucosal surface by highlighting the contrast of deepened and raised areas. The increasing prevalence of colon cancer is propelling the growth of the market.

Increasing demand for endoscopy procedures and increasing prevalence of gastrointestinal diseases as well as cancer are the major factors driving the chromoendoscopy agents market growth. Furthermore, the advantages of chromoscopy over conventional endoscopy is likely to favor the expansion of the market. According to the American Journal of Gastroenterology, around 1 million people in the U.S. and Europe are affected by ulcerative colitis. This is anticipated to fuel market growth.

However, many healthcare professionals have restricted prescribing chromoendoscopy to high-risk patients where finding the lesions will be meaningful. This, coupled with the presence of alternative techniques such as narrow-band imaging, is expected to hinder the growth of the market.

Market Segmentation:

By product type, the global chromoendoscopy agents market can be segmented into reactive agents, contrast agents, and absorptive agents. On the basis of application, the market can be bifurcated into gastrointestinal diseases, colorectal diseases, and esophageal diseases, and others. In terms of end user, the market can be segmented into hospitals, diagnostic laboratories, clinics, and others

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The major companies in the global chromoendoscopy agents market report include LobaChemie Pvt. Ltd., COSMO Pharmaceuticals NV, Enzo Life Sciences Inc., Provepharm Life Solutions, Thermo Fisher Scientific Inc., Sisco Research Laboratories Pvt. Ltd., and others.

Key Insights

• Technological Advancements in the Chromoendoscopy Agents


• Prevalence of Colon Cancer – For Key Countries/ Regions


• Prevalence of Gastric Cancer – For Key Countries/ Regions


• COVID-19 Impact on the Global Chromoendoscopy Agents Market


• Key Industry Developments – New Product Launches, Mergers, Acquisitions, and Partnerships

Regional Analysis:

The global chromoendoscopy agents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the market throughout the forecast period. Primary factors responsible for the growth of the market are the increasing demand for advanced diagnostic tools, favorable health reimbursement, and the increasing number of endoscopic procedures. In Europe, the market is poised to surge, owing to the rising prevalence of cancer. According to WHO, the incidence of colon cancer is projected to reach 349,000 by 2025 in Europe. This is expected to foster the market in Europe. In Asia Pacific, the market is projected to witness remarkable growth owing to the rising geriatric population and technological advancements. In Latin America and the Middle East & Africa, the market is estimated to grow owing to active government support in training of healthcare workers and improving health infrastructure.

Segmentation

Chromoendoscopy Agents Industry Developments

• In November 2018, SonoScape Medical Corp launched its corporate brand in India. The company exhibited HD-350, its endoscopy system: HD-500 image processor at Annual Conference of the Indian Society of Gastroenterology. The HD-500 is equipped with the company’s chromoscopy technology.